Rekomendatsii AASLD po lecheniyu nealkogol'noy zhirovoy bolezni pecheni. Vozmozhnost' ispol'zovaniya v Rossii
- Autores: Grinevich V.B1, Sas E.I1, Kravchuk Y.A1, Efimov O.I1
-
Afiliações:
- Edição: Nº 2 (2014)
- Páginas: 76-79
- Seção: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/286609
- ID: 286609
Citar
Texto integral
Acesso aberto
Acesso está concedido
Acesso é pago ou somente para assinantes
Resumo
Growth in the number of overweight people around the world maintains an interest in the diagnosis and treatment of nonalcoholic fatty liver disease (NAFLD). Output in 2012 the American College of Gastroenterology Management (American College of Gastroenterology - ACG) and the American Association of Gastroenterology (American Gastroenterological Association - AGA) for the diagnosis and management of patients with NAFLD (Manual ACG / AGA) can largely facilitate the work of medical practitioners. This publication is devoted to a brief overview.
Palavras-chave
Texto integral
Bibliografia
- Chalasani N., Younossi Z., Lavine J.E., et al. The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Am. J. Gastroenterol. 2012; 107: 811-26
- Пиманов С.И. Американские рекомендации по диагностике и лечению неалкогольной жировой болезни печени: кое- что проясняется. Cons. Med. Гастроэнтерология. 2012; 2: 80-5.
- Ratziu V., de Ledinghen V., Oberti F., et al. Arandomized controlled trial of high-dose Ursodeoxycholic acid for non-alcoholic steatohepatitis. J. Hepatol. 2011; 13(5): 1011-9. doi: 10.1016/j.jhep. 2010.08.030.
- Kidd P.M. Cell membranes, endothelia, and atherosclerosis the importance of Phosphatidylcholine. Altern. Med. Rev. 1996; 1: 148-67.
Arquivos suplementares
